Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Reversal of Childhood Overweight May Prevent Later CHD Risks

Todd Neale

December 03, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

Todd Neale

November 13, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

Caitlin E. Cox

July 23, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Taxing Sugar-Sweetened Drinks Modestly Impacts BMI

L.A. McKeown

February 05, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Women’s Heart Health in the Spotlight

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Reversal of Childhood Overweight May Prevent Later CHD Risks

Frail Patients Stand to Gain Most From Cardiac Rehab

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

June 2025 Dispatch for the CV Team

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Taxing Sugar-Sweetened Drinks Modestly Impacts BMI

AHA Stats Show CV Health of Americans Remains Dire

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content